News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,705 Results
Type
Article (8021)
Company Profile (140)
Press Release (476543)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166755)
Career Advice (305)
Deals (25741)
Drug Delivery (7)
Drug Development (52878)
Employer Resources (14)
FDA (9760)
Job Trends (8575)
News (238200)
Policy (17906)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (487)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33155)
ALS (105)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (263)
Approvals (10376)
Artificial intelligence (322)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6959)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (508)
Cancer (3648)
Cardiovascular disease (217)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47871)
Collaboration (1247)
Commercialization (3)
Compensation (1470)
Complete response letters (34)
COVID-19 (755)
CRISPR (64)
C-suite (748)
Cystic fibrosis (85)
Data (5655)
Denatured (4)
Depression (102)
Dermatology (61)
Diabetes (344)
Diagnostics (4187)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (156)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73716)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87615)
Executive appointments (701)
FDA (12389)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (919)
Gene editing (126)
Generative AI (9)
Gene therapy (318)
GLP-1 (290)
Government (942)
Grass and pollen (2)
Guidances (281)
Healthcare (9317)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (943)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (41)
IPO (12389)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (60)
Legal (5195)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (534)
Marketing (8)
MASH (118)
Medical device (8655)
Medtech (8800)
Mergers & acquisitions (14384)
Metabolic disorders (707)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1824)
NextGen: Class of 2026 (3152)
Non-profit (841)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (172)
Pancreatic cancer (196)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (508)
Peanut (31)
People (41237)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15468)
Phase 2 (21379)
Phase 3 (14401)
Pipeline (7329)
Policy (18)
Postmarket research (1570)
Preclinical (6540)
Press Release (34)
Prostate cancer (190)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (573)
Real estate (3019)
Recruiting (6)
Regulatory (14819)
Reports (21)
Research institute (582)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2021)
Stomach cancer (3)
Supply chain (50)
Vaccines (322)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Today (18)
Last 7 days (210)
Last 30 days (1553)
Last 365 days (19014)
2026 (12315)
2025 (19253)
2024 (22986)
2023 (26539)
2022 (34591)
2021 (37173)
2020 (33471)
2019 (23262)
2018 (17494)
2017 (18766)
2016 (17921)
2015 (24269)
2014 (21683)
2013 (18137)
2012 (20221)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17890)
Australia (2098)
California (11975)
Canada (3148)
China (524)
Colorado (484)
Connecticut (409)
Delaware (208)
Europe (24629)
Florida (1789)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (699)
India (51)
Indiana (314)
Iowa (15)
Japan (400)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1202)
Massachusetts (7859)
Michigan (308)
Minnesota (559)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2621)
New Mexico (12)
New York (2822)
North Carolina (1279)
North Dakota (4)
Northern California (6000)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2253)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4973)
Tennessee (120)
Texas (1940)
United States (38877)
Utah (360)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (928)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,705 Results for "benchling inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Benchling and Baseten Partner to Bring AI Inference to Biotech R&D
May 20, 2026
·
3 min read
Press Releases
Benchling Biologics delivers no-code antibody format design and automated registration at scale
May 11, 2026
·
5 min read
Press Releases
Benchling and Moderna Collaborate on AI-Driven Research
May 7, 2025
·
2 min read
Business
Benchling Announces New Executive Appointments and 1,000 Customer Milestone
Benchling, the R&D Cloud powering the biotechnology industry, announced the appointment of new executive leadership to its engineering and field organizations.
August 25, 2022
·
3 min read
Deals
Benchling Acquires Overwatch Research to Accelerate Breakthroughs for Biopharma Companies
Benchling, pioneer of the R&D Cloud powering the biotechnology industry, announced it has acquired Overwatch Research, a Belfast-based startup creating software to accelerate in vivo research.
February 24, 2022
·
5 min read
Biotech Bay
Benchling Launches the First Complete Solution for RNA R&D to Accelerate mRNA and RNA Therapeutics Development
Benchling, the R&D Cloud powering the biotechnology industry, launched the industry’s first full set of capabilities for designing, modeling, and studying both natural and chemically modified RNA in a single solution.
September 7, 2022
·
6 min read
Biotech Bay
Benchling Launches Pioneering Biology Education Initiative
Benchling for Education expands academic market leadership to help teachers working remotely engage the next generation of biotech innovators
February 25, 2021
·
3 min read
Biotech Bay
Benchling Launches Support for the Discovery and Development of RNA Therapeutics
Benchling, the leading life sciences cloud, today announced the launch of a digital solution for scientists to design, analyze, and develop complex RNA therapeutics in a unified R&D platform for the first time.
June 22, 2021
·
4 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Biotech Bay
Benchling Raises $200M Series E To Accelerate Biotech R&D
Benchling, the leading life sciences R&D cloud, has raised $200 million in Series E funding led by Sequoia Capital Global Equities and joined by Altimeter Capital, Byers Capital and Elad Gil. Existing investors participated, including Thrive Capital, Benchmark, Menlo Ventures, Alkeon Capital, ICONIQ, Lux Capital, Spark Capital and Lead Edge Capita
April 14, 2021
·
3 min read
1 of 48,471
Next
